Natrapharm
Natrapharm, Inc. is a privately held Filipino pharmaceutical company that provides quality medicines to the Filipino market and operates the Natrapharm-HIP digital health platform, offering free virtual consultations with over 7,000 doctors nationwide.
- Company typePrivate
- Founded1990
- HeadquartersParañaque, Philippines
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Natrapharm does
Natrapharm, Inc. is a privately held Filipino pharmaceutical company headquartered in the Philippines that provides quality medicines to the Filipino market and runs the Natrapharm Health Information Program (Natrapharm-HIP), a digital health platform. The company also offers business services for partners seeking to navigate the Philippine pharmaceutical market, leveraging what it describes as a combination of global perspective and local expertise.
The company's core offering comprises two pillars: a portfolio of pharmaceutical products evaluated against high safety and efficacy standards, and the Natrapharm-HIP platform. HIP, launched in 2020 during the COVID-19 pandemic, is a public service platform hosted at hips-md.com that connects patients with over 7,000 doctors nationwide across various medical specialties for free virtual consultations. The platform supports online and in-person appointment scheduling, patient records access, and electronic prescription management. The company distributes through its corporate website (natrapharm.com) and the HIP digital platform, with a medical updates blog serving as a content marketing channel.
Natrapharm's revenue model is not publicly disclosed, and pricing for pharmaceutical products is not available on the website. The HIP consultation service is explicitly free, suggesting it functions as a brand-building and healthcare-access initiative rather than a direct revenue stream. The company targets the general Filipino public as its primary customer segment, with a secondary focus on business partners seeking market entry or distribution support in the Philippines.
Natrapharm firmographics
Firmographics- Name
- Natrapharm
- Legal name
- Natrapharm, Inc.
- Website
- https://natrapharm.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Natrapharm, Inc. is a privately held Filipino pharmaceutical company that provides quality medicines to the Filipino market and operates the Natrapharm-HIP digital health platform, offering free virtual consultations with over 7,000 doctors nationwide.
- Ownership category
- akta.pro rank
Natrapharm industry classification
Industry- Product category
- Pharmaceutical Products
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industries
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Medication Adherence, Reminders & Patient Support (HLACAKAF)
Keywords
Where Natrapharm is headquartered
LocationHeadquarters
- HQ city
- Parañaque
- HQ country
- Philippines
- HQ region
- Asia
Markets served
Natrapharm business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Distribution channels2 records
Marketing channels3 records
Natrapharm product offering
Product offeringCore offering
Natrapharm, Inc. is a Philippine pharmaceutical company that manufactures and distributes quality medicines evaluated with high standards of safety and efficacy for the Filipino market. The company also operates the Natrapharm Health Information Program (Natrapharm-HIP), a public service digital healthcare platform providing free virtual consultations with over 7,000 doctors nationwide, online and in-person appointment scheduling, patient records access, and electronic prescriptions. In addition, Natrapharm offers business partnership services that combine global perspective with local Philippine market expertise.
Product overview
Natrapharm, Inc. is a Filipino pharmaceutical company focused on providing quality medicines and healthcare accessibility to Filipinos. The company's main offerings include quality pharmaceutical products (evaluated with high safety and efficacy standards) and the Natrapharm Health Information Program (Natrapharm-HIP) - a public service platform providing free virtual consultations with over 7,000 doctors nationwide, appointment scheduling (online and in-person), patient records access, and electronic prescriptions. The company also offers business partnership services with global perspective and local expertise.
Differentiator
Problem solved
Functional benefit
Brands
- Natrapharm Health Information Program (Natrapharm-HIP): A public service platform by Natrapharm offering free virtual consultations with doctors, online and in-person appointment scheduling, and access to patient records and electronic prescriptions.
Products and services
- Quality Pharmaceutical Medicines
Quantifiable outcome
- Over 7,000 doctors available nationwide for virtual consultations
Companies that use Natrapharm
Customer profileSegments2 records
Ideal customer profiles2 records
Natrapharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Natrapharm partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Natrapharm competitors and assessment
Company assessmentBroad incumbents
- Novartis Philippines: Novartis Philippines markets innovative prescription medicines across cardiovascular, oncology, and immunology in the Philippines. Comparable as a multinational pharma incumbent competing in the same prescription drug channels as Natrapharm.
- GlaxoSmithKline Philippines: GSK Philippines distributes prescription pharmaceuticals, vaccines, and consumer health products in the Philippine market. Comparable as a multinational pharma competitor in overlapping therapeutic categories, though with substantially greater scale and R&D capacity.
- Roche Philippines: Roche Philippines markets pharmaceuticals and diagnostics products in the Philippines, with strength in specialty therapeutic areas. Comparable as a multinational pharma incumbent competing in prescription channels that Natrapharm's ePrescription platform feeds into.
- AstraZeneca Philippines: AstraZeneca Philippines distributes prescription pharmaceuticals across respiratory, cardiovascular, and oncology therapeutic areas in the Philippines. Comparable as a multinational pharma competitor targeting the same physician channels and patient populations.
- Pfizer Philippines: Pfizer Philippines is the local affiliate of a global pharmaceutical major, distributing branded prescription and OTC medicines in the Philippines. It competes with Natrapharm's pharmaceutical product lines but operates as part of a much broader multinational portfolio.
Direct peers
- Unilab: Unilab is the largest Filipino pharmaceutical company, manufacturing and distributing a broad range of branded and generic medicines across the Philippines. It is a direct peer given overlapping product portfolio, Philippine market focus, and similar local brand positioning to Natrapharm.
- Pascual Laboratories: Pascual Laboratories is a Filipino pharmaceutical manufacturer with a heritage comparable to Natrapharm's, producing branded generics and consumer health products primarily for the Philippine market. Comparable as a homegrown Philippine pharma player with similar distribution and brand positioning.
Emerging players
- mWell: mWell is a Philippine telehealth and digital health platform operated by Metro Pacific Health Tech, offering virtual consultations and integrated health services. Comparable as an emerging player in Philippine virtual care with overlapping patient base and consultation services.
- HealthNow Philippines: HealthNow is a Philippine telehealth and medicine delivery app offering video consultations and same-day prescription delivery. Comparable as an emerging player combining telehealth with pharmacy fulfillment, intersecting directly with Natrapharm-HIP's value proposition.
- KonsultaMD: KonsultaMD is a Philippines-focused telehealth platform offering on-demand virtual doctor consultations via subscription and per-consult pricing. Comparable as a direct telehealth competitor serving Filipino consumers, though it lacks Natrapharm's captive pharma supply chain.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Natrapharm social profiles
Digital presenceNatrapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Natrapharm leadership team
Management profileNumber of profiles
Natrapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Natrapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Natrapharm
What does Natrapharm do?
Natrapharm, Inc. is a Philippine pharmaceutical company that manufactures and distributes quality medicines evaluated with high standards of safety and efficacy for the Filipino market. The company also operates the Natrapharm Health Information Program (Natrapharm-HIP), a public service digital healthcare platform providing free virtual consultations with over 7,000 doctors nationwide, online and in-person appointment scheduling, patient records access, and electronic prescriptions. In addition, Natrapharm offers business partnership services that combine global perspective with local Philippine market expertise.
Is Natrapharm a public or private company?
Natrapharm is a private company. It is classified as unknown and is currently operating.
When was Natrapharm founded?
Natrapharm was founded in 1990. It employs 1 to 10 people.
Where is Natrapharm based?
Natrapharm is headquartered in Parañaque, Philippines, in the Asia region.
Who are Natrapharm's main competitors?
Broad incumbents on record are Novartis Philippines, GlaxoSmithKline Philippines, Roche Philippines, AstraZeneca Philippines and Pfizer Philippines. Direct peers are Unilab and Pascual Laboratories. Emerging players are mWell, HealthNow Philippines and KonsultaMD.
Does Natrapharm have an API?
No public API is recorded for Natrapharm.
What industry is Natrapharm in?
Natrapharm's product category is Pharmaceutical Products. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 325412 and its SIC code is 2834.